Revenue

The nation's largest single-family landlord posts strong profits but faces slowing rent growth, shifting its strategy from buying homes to building them.

With impressive preliminary sales and key pipeline updates, Mirum Pharmaceuticals' upcoming earnings call will focus on its strategy for sustained growth in 2026.

The AI analytics firm posted strong 2025 results, unveiled new AI agents, and boosted its buyback program, signaling confidence in its enterprise strategy.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

The Dubai-based SPAC is separating its shares and warrants. Here's what this key move means for investors and the company's search for a merger target.

Record annual revenue driven by a diverse brand portfolio and aggressive expansion masks a comparable sales slowdown at its iconic flagship restaurants.

Lexington-based insurer Mountain Life promises agents unmatched personal service. But can this high-touch model survive a new owner's ambitious growth plans?

TPL shatters 2025 financial records despite price headwinds, fueled by strategic acquisitions and a major $50 million investment in data infrastructure.

Herbalife posts strong sales growth and gets a major boost from Cristiano Ronaldo's investment in its new personalized nutrition tech platform, Pro2col.

Wyndham Hotels & Resorts reports record development but takes a major Q4 loss from a franchisee's insolvency, yet signals confidence with a dividend hike.

The Canadian insurer posted a massive profit increase, turning around its underwriting performance thanks to fewer catastrophes and higher premium revenue.

Aurora executives face Wall Street at key March conferences to justify high cash burn with a clear path to commercializing their driverless truck tech.

A landmark deal with Abu Dhabi's SSMC will make the UAE a regional hub for Nyxoah's innovative Genio implant, targeting a major health issue.

The global underwriter posts stellar earnings, announces strategic acquisitions in the travel sector, and launches a $100M share buyback.

As Teladoc faces slowing growth, the virtual care giant adds insurance titan Michael Smith to its board, signaling a push for financial discipline.

Caesarstone will release its 2025 results without a conference call, a move raising investor questions amid a year of losses and strategic overhaul.

Compass Diversified sets its earnings date, putting its post-Lugano strategy and portfolio health under intense scrutiny from investors.

Seer, Inc. heads to the TD Cowen conference, putting its innovative proteomics technology and market strategy under the investor microscope.

As its CFO prepares for a key investor conference, O-I Glass must reconcile its strong operational gains with market skepticism and competitive pressures.

The NYSE-listed medtech firm will detail its "ecosystem" strategy for the booming shoulder surgery market amid rapid revenue growth and a push for profitability.